Patents by Inventor Hong Jae JEON

Hong Jae JEON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11991902
    Abstract: A display device includes a bank including an opening exposing a surface of a base. The bank further includes side surfaces adjacent to an upper surface. The side surfaces slope downward from the upper surface toward an opening in an organic film pattern. A plurality of fine holes is formed on the upper surface and the side surfaces, the bank may also include a plurality of inner holes.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: May 21, 2024
    Assignee: Samsung Display Co., Ltd.
    Inventors: Myung Hwan Kim, Suk Hoon Kang, Min Jae Kim, Hee Ra Kim, Beom Soo Shin, Hong Yeon Lee, Baek Kyun Jeon
  • Patent number: 11932618
    Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.
    Type: Grant
    Filed: March 13, 2023
    Date of Patent: March 19, 2024
    Assignee: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Hong Chul Yoon, Kyung Mi An, Myong Jae Lee, Jin Hee Lee, Jeong-geun Kim, A-rang Im, Woo Jin Jeon, Jin Ah Jeong, Jaeho Heo, Changhee Hong, Kyeojin Kim, Jung-Eun Park, Te-ik Sohn, Changmok Oh, Da Hae Hong, Sung Wook Kwon, Jung Ho Kim, Jae Eui Shin, Yeongran Yoo, Min Whan Chang, Eun Hye Jang, In-gyu Je, Ji Hye Choi, Gunhee Kim, Yearin Jun
  • Publication number: 20230241141
    Abstract: Provided are a pharmaceutical composition including reovirus or reovirus-treated biological sample as an active ingredient for prevention or treatment of cancer, and a method for prevention or treatment of cancer using same. In addition, provided are a combination use of the pharmaceutical composition and an immune checkpoint inhibitor for treatment of cancer.
    Type: Application
    Filed: April 7, 2021
    Publication date: August 3, 2023
    Applicant: VIROCURE, INC.
    Inventors: Haeng Jun YOO, Sang Kyoung HAN, Yeon Sook LEE, Chan KIM, Hong Jae JEON
  • Patent number: 11370758
    Abstract: Provided is an inhibitor of an indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) of formula (I) or a pharmaceutically acceptable salt thereof: in which W1, W2, W3, and W4, X, Y, Z1, Z2, and R1-7 are described herein. Further provided is a method of treating or preventing a IDO and/or TDO-mediated disease using an effective amount of the compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 28, 2022
    Assignees: CMG PHARMACEUTICAL CO., LTD., SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hong Jae Jeon, Chan Kim, Na Keum Lee, Jin Sung Kim, Hye Sun Jeon, Young Eun Kwon, Ju Hui Jeong
  • Publication number: 20190292150
    Abstract: Provided is an inhibitor of an indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) of formula (I) or a pharmaceutically acceptable salt thereof: in which W1, W2, W3, and W4, X, Y, Z1, Z2, and R1-7 are described herein. Further provided is a method of treating or preventing a IDO and/or TDO-mediated disease using an effective amount of the compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Applicants: CMG PHARMACEUTICAL CO., LTD., SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hong Jae JEON, Chan KIM, Na Keum LEE, Jin Sung KIM, Hye Sun JEON, Young Eun KWON, Ju Hui JEONG